SK-II sales jumped 40% in China during the firm's fiscal 2018 first quarter, and Olay also was up in the mid-teens, P&G reports. Execs discussed hair-care innovations in the country and the importance of engaging Chinese millennials during the firm's Q1 call with analysts.
Procter & Gamble Co. leadership focused on China during the firm's fiscal 2018 first-quarter earnings call Oct. 20, highlighting beauty brands and innovations that are driving its turnaround in the country.
Overall sales were up 1% for the quarter to $16.7bn, P&G reported, citing a decelerating global market and challenging comparisons....
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
